LGND · Ligand Pharmaceuticals Inc
$288.01
-8.27 (-2.79%)
At close · Jul 29
Market Cap
$5.94B
Shares
20.04M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-05-04 | 392,830 | 287,447 | 680,277 | 48.4% |
| 2026-04-27 | 336,686 | 197,227 | 533,913 | 44.4% |
| 2026-04-20 | 150,140 | 191,087 | 341,227 | 48.9% |
| 2026-04-13 | 373,667 | 238,150 | 611,817 | 43.5% |
| 2026-04-06 | 237,369 | 107,723 | 345,092 | 29.5% |
| 2026-03-30 | 189,550 | 144,941 | 334,491 | 37.4% |
| 2026-03-23 | 171,082 | 274,439 | 445,521 | 40.5% |
| 2026-03-16 | 285,552 | 240,171 | 525,723 | 40.5% |
| 2026-03-09 | 417,195 | 316,672 | 733,867 | 47.2% |
| 2026-03-02 | 225,552 | 172,014 | 397,566 | 39.8% |
| 2026-02-23 | 275,469 | 136,443 | 411,912 | 45.1% |
| 2026-02-16 | 160,747 | 129,941 | 290,688 | 48.3% |
| 2026-02-09 | 295,116 | 221,848 | 516,964 | 47.9% |
| 2026-02-02 | 219,366 | 173,638 | 393,004 | 42.5% |
| 2026-01-26 | 247,943 | 129,135 | 377,078 | 42.3% |
| 2026-01-19 | 254,952 | 187,389 | 442,341 | 49.6% |
| 2026-01-12 | 629,606 | 410,370 | 1,039,976 | 50.3% |
| 2026-01-05 | 192,668 | 136,732 | 329,400 | 43.4% |
| 2025-12-29 | 136,592 | 166,945 | 303,537 | 48.8% |
| 2025-12-22 | 100,259 | 86,206 | 186,465 | 43.4% |
| 2025-12-15 | 275,037 | 378,005 | 653,042 | 45.0% |
| 2025-12-08 | 254,135 | 197,134 | 451,269 | 40.7% |
| 2025-12-01 | 326,874 | 172,441 | 499,315 | 42.8% |
| 2025-11-24 | 207,469 | 125,485 | 332,954 | 38.1% |
| 2025-11-17 | 343,403 | 108,528 | 451,931 | 36.9% |
| 2025-11-10 | 263,321 | 308,077 | 571,398 | 52.6% |
| 2025-11-03 | 363,892 | 238,393 | 602,285 | 42.7% |
| 2025-10-27 | 234,038 | 270,501 | 504,539 | 50.9% |
| 2025-10-20 | 171,312 | 78,149 | 249,461 | 45.3% |
| 2025-10-13 | 127,437 | 102,203 | 229,640 | 40.1% |
| 2025-10-06 | 138,630 | 146,224 | 284,854 | 49.0% |
| 2025-09-29 | 355,452 | 88,599 | 444,051 | 46.5% |
| 2025-09-22 | 217,009 | 119,184 | 336,193 | 42.1% |
| 2025-09-15 | 519,494 | 357,802 | 877,296 | 43.5% |
| 2025-09-08 | 241,768 | 306,474 | 548,242 | 54.2% |
| 2025-09-01 | 143,515 | 181,810 | 325,325 | 49.7% |
| 2025-08-25 | 163,234 | 128,953 | 292,187 | 44.2% |
| 2025-08-18 | 177,845 | 182,465 | 360,310 | 45.0% |
| 2025-08-11 | 907,183 | 1,368,127 | 2,275,310 | 62.3% |
| 2025-08-04 | 336,152 | 112,624 | 448,776 | 41.3% |
Showing 1–40 of 40 weeks
Key facts
CIK
886163
CUSIP
53220K504
13F (30d)
105 filings
102 filers
Visit website
Investor relations